FRESH TRACKS THERAPEUTICS IN (FRTX) Forecast, Price Target & Analyst Ratings

NASDAQ:FRTX • US10802T2042

Current stock price

0.79 USD
-0.02 (-2.48%)
At close:
0.77 USD
-0.02 (-2.53%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for FRESH TRACKS THERAPEUTICS IN (FRTX).

Forecast Snapshot

Consensus Price Target

Price Target
$4.59
+ 481.01% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Mar 28, 2024
Period
Q4 / 2023
EPS Estimate
-$1.54
Revenue Estimate
510K
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
82.86%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$4.59
Upside
+ 481.01%
From current price of $0.79 to mean target of $4.59, Based on 7 analyst forecasts
Low
$4.55
Median
$4.59
High
$4.73

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

7 Wall Street analysts provided a forecast for the next 12 months for FRTX. The average price target is 4.59 USD. This implies a price increase of 481.01% is expected in the next year compared to the current price of 0.79.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

FRTX Current Analyst RatingFRTX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

FRTX Historical Analyst RatingsFRTX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -11 -10 -9 -8 -7 -6 -5 -4 -3 -2 -1 0 2 4 6 8

Analyst Ratings Consensus

ChartMill Buy Consensus
82.86%
FRTX was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about FRTX.
In the previous month the buy percentage consensus was at a similar level.
FRTX was analyzed by 7 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

Next Earnings Forecast Details

Next Earnings Details

Release Date
Mar 28, 2024
Period
Q4 / 2023
EPS Estimate
-$1.54
Revenue Estimate
510K
Revenue Q2Q
-75.12%
EPS Q2Q
-20.32%
Number of Analysts
4

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
0.00%
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%

Next Earnings Summary

FRTX is expected to report earnings on 3/28/2024. The consensus EPS estimate for the next earnings is -1.54 USD and the consensus revenue estimate is 510.00K USD.
The next earnings revenue estimate has been revised downward by 0% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2023 - 2024

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2020 2021 2022 2023 2024
Revenue
YoY % growth
FRTX revenue by date.FRTX revenue by date.
1.82M
-77.02%		400K
-78.02%		6.94M
1,635.00%		3.06M
-55.91%		6.12M
100.00%
EBITDA
YoY % growth
FRTX ebitda by date.FRTX ebitda by date.
-20.97M
-6.77%		-40.22M
-91.80%		-21.5M
46.54%		N/AN/A
EBIT
YoY % growth
FRTX ebit by date.FRTX ebit by date.
-20.98M
-6.66%		-40.24M
-91.80%		-21.53M
46.50%		-23.169M
-7.61%		N/A
Operating Margin
FRTX operating margin by date.FRTX operating margin by date.
-1,152.75%-10,060.00%-310.23%-757.15%N/A
EPS
YoY % growth
FRTX eps by date.FRTX eps by date.
N/A-23.85
26.82%		N/A
68.95%		-7.00
5.44%		-6.91
1.38%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 23 Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24
EPS
Q2Q % growth		-1.54
-20.32%		-1.72
-2.42%		-1.86
-8.33%		-1.10
-444.25%		-2.21
-43.71%
Revenue
Q2Q % growth		510K
-75.12%		510K
5,000.00%		510K
920.00%		4.59M
-42.19%		510K
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/A
EBIT
Q2Q % growth		N/AN/AN/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

FRTX Yearly Revenue VS EstimatesFRTX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
FRTX Yearly EPS VS EstimatesFRTX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2020 2021 2022 2023 2024 -100 -200 -300 -400

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
N/A
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

FRESH TRACKS THERAPEUTICS IN / FRTX Forecast FAQ

What do analysts expect the price target to be for FRESH TRACKS THERAPEUTICS IN (FRTX)?

7 analysts have analysed FRTX and the average price target is 4.59 USD. This implies a price increase of 481.01% is expected in the next year compared to the current price of 0.79.

Can you provide the upcoming earnings date for FRESH TRACKS THERAPEUTICS IN?

FRESH TRACKS THERAPEUTICS IN (FRTX) will report earnings on 2024-03-28, after the market close.

What are the consensus estimates for FRESH TRACKS THERAPEUTICS IN (FRTX) next earnings?

The consensus EPS estimate for the next earnings of FRESH TRACKS THERAPEUTICS IN (FRTX) is -1.54 USD and the consensus revenue estimate is 510.00K USD.